NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
about
Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathwayTherapeutic strategies for inhibiting invasion in glioblastoma.Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response.RNAi-mediated downregulation of MMP-2 activates the extrinsic apoptotic pathway in human glioma xenograft cellsSensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss.Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma.Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling.Type I IFNs signaling and apoptosis resistance in glioblastoma cells.Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
P2860
Q27468806-A315F9B0-FF5F-4358-AFC9-0A3795ED6F98Q33426563-6C5E2BC0-7AAB-4503-9FA6-4D729EA39A5DQ33872837-7C0E10A2-8FD6-45A2-9A8F-AC36C7D3A3B7Q33939106-50F8C3B2-3A20-4901-BD1D-263351D2774AQ34543666-85C3D263-A4B2-4146-916D-3BF274EFB99EQ34786865-FE35A2CF-C1E5-47ED-A75F-3C722ECA447FQ35832054-169FCF41-FE92-4714-BB8F-4AA2D1B7E556Q37335918-B04C8FEC-3A0F-4DE1-B228-E204F991961EQ37589832-A5635D65-B803-4905-8696-46E29EE3D737Q38111684-F409E854-288C-46B6-A778-E8FF0F484C7DQ39389835-20AD3B6B-E132-4232-B54E-A8B2CC7DC9DFQ39486541-21FF7F58-A4FC-4FF0-A3BC-5DEFCBD1A2D1Q39990380-97059C49-3E1E-4EE6-93DD-2607C4BDD052Q40002391-52107F39-904E-4759-B2F7-0917B56F7AF7
P2860
NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
NF-kappaB-independent sensitiz ...... osis by proteasome inhibition.
@en
NF-kappaB-independent sensitiz ...... osis by proteasome inhibition.
@nl
type
label
NF-kappaB-independent sensitiz ...... osis by proteasome inhibition.
@en
NF-kappaB-independent sensitiz ...... osis by proteasome inhibition.
@nl
prefLabel
NF-kappaB-independent sensitiz ...... osis by proteasome inhibition.
@en
NF-kappaB-independent sensitiz ...... osis by proteasome inhibition.
@nl
P2093
P50
P356
P1433
P1476
NF-kappaB-independent sensitiz ...... tosis by proteasome inhibition
@en
P2093
H Kasperczyk
K La Ferla-Brühl
P2888
P304
P356
10.1038/SJ.ONC.1209841
P407
P577
2006-08-07T00:00:00Z
P5875
P6179
1018845904